Hepatitis B
📧 Sign up to get email alerts when something new happens for Hepatitis B.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2008-06-16Clinical Trial Update: Safety, Immunogenicity and Reactogenicity of Recombinant Hepatitis B Vaccine (Adjuvanted & New Formulation) and Engerix™-B [Phase 3]
Phase 3 study evaluating safety, immunogenicity and reactogenicity of an adjuvanted recombinant Hepatitis B vaccine with a new formulation a…
-
CLINICAL_TRIALS trial_result · 2008-06-16Clinical Trial Update: Evaluation of Immunogenicity and Reactogenicity of Various Formulations of Recombinant Hepatitis B Vaccine [Phase 3]
Phase 3 trial update evaluating immunogenicity and reactogenicity of various formulations of recombinant hepatitis B vaccine conducted by Gl…
-
CLINICAL_TRIALS trial_result · 2008-06-13Clinical Trial Update: Immunogenicity & Reactogenicity of Various Formulations of Recombinant Hepatitis B Vaccine With Different Adjuvants [Phase 2]
Phase 2 trial evaluating immunogenicity and reactogenicity of multiple formulations of recombinant hepatitis B vaccine with different adjuva…
-
CLINICAL_TRIALS trial_result · 2008-06-13Clinical Trial Update: Comparison of Immuno, Reacto and Safety of Recombinant Hepatitis B Vaccine With or Without MPL in Healthy Older Adults [Phase 3]
Phase 3 trial comparing the immunogenicity and safety of recombinant hepatitis B vaccine with MPL adjuvant versus without MPL in healthy old…
-
CLINICAL_TRIALS trial_result · 2008-06-13Clinical Trial Update: Immunogenicity & Reactogenicity of HBV-MPL Vaccine and Engerix™-B in Healthy Adults Following 2 Different Schedules [Phase 2]
Phase 2 clinical trial comparing the immunogenicity and reactogenicity of HBV-MPL vaccine and Engerix-B across two dosing schedules in healt…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2008-06-13Clinical Trial Update: Study Comparing Immunogenicity, Reactogenicity and Safety of GSK Bios' HBV-MPL Vaccine With That of Engerix™-B in Adults [Phase 3]
A Phase 3 study comparing the immunogenicity, reactogenicity, and safety of GSK's HBV-MPL vaccine versus Engerix-B in adults with Hepatitis …
-
CLINICAL_TRIALS trial_result · 2008-06-13Clinical Trial Update: Immunogenicity and Safety of GSK Biologicals' HBV-MPL Vaccine and Engerix™-B in Healthy Adults (15-40 Yrs). [Phase 3]
Phase 3 trial update reporting immunogenicity and safety data for GSK's HBV-MPL vaccine and Engerix-B in healthy adults aged 15-40; the stud…
-
CLINICAL_TRIALS trial_result · 2008-06-13Clinical Trial Update: Safety and Immunogenicity of 3 Lots of GSK Biologicals' HBV-MPL Vaccine and Engerix™-B in Healthy Volunteers ≥ 15y [Phase 3]
This Phase 3 trial completed, evaluating the safety and immunogenicity of three lots of GSK's HBV-MPL vaccine together with Engerix-B in hea…
-
FDA approval · 2008-06-03FDA Approved: BARACLUDE — Supplemental Application (E.R. Squibb & Sons, L.L.C.)
The FDA approved a supplemental application for Baraclude (entecavir) submitted by E.R. Squibb & Sons, L.L.C.
-
FDA approval · 2008-06-03FDA Approved: BARACLUDE — Supplemental Application (E.R. Squibb & Sons, L.L.C.)
FDA approved a supplemental application for Baraclude (entecavir) submitted by E.R. Squibb & Sons, L.L.C.
-
CLINICAL_TRIALS trial_result · 2008-04-23Clinical Trial Update: Entecavir for Patients With Decompensated Hepatitis B Virus (HBV)-Related Cirrhosis [Phase 4]
Phase 4 clinical trial evaluating entecavir in patients with decompensated HBV-related cirrhosis; the trial status is currently unknown.
-
CLINICAL_TRIALS research · 2008-04-17Clinical Trial Update: A Surveillance Program for the Detection of Hepatitis B Virus (HBV) Resistance to Tenofovir in HIV-HBV co-Infected Patients
A surveillance program update on detecting hepatitis B virus resistance to tenofovir in HIV-HBV co-infected patients.
-
CLINICAL_TRIALS trial_result · 2008-04-10Clinical Trial Update: PK Study of Tacrolimus and Cyclosporine When Co-Administered With Adefovir Dipivoxil in Post-Liver Transplant Patients [Phase 2]
Phase 2 pharmacokinetic study evaluating interactions between tacrolimus and cyclosporine when co-administered with adefovir dipivoxil in po…
-
CLINICAL_TRIALS research · 2008-04-02Clinical Trial Update: HIV-HBV Co-Infection and Liver Disease
An update on a clinical trial investigating HIV infection with Hepatitis B co-infection and related liver disease; the current trial status …
-
CLINICAL_TRIALS trial_result · 2008-03-27Clinical Trial Update: Open Label Study of Pharmacokinetics and Safety of Dose of Adefovir Dipivoxil in Children and Adolescents With HBV [Phase 1, Phase 2]
Open-label pharmacokinetics and safety study of adefovir dipivoxil in children and adolescents with hepatitis B has completed, providing PK …
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Lamivudine for Chronic Hepatitis B [Phase 2]
This update reports the completion of a Phase 2 trial evaluating lamivudine for chronic hepatitis B. The study also involved related conditi…
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Lamivudine and Adefovir to Treat Chronic Hepatitis B Infection in People With and Without HIV Infection [Phase 3]
Phase 3 trial evaluating lamivudine in combination with adefovir for chronic hepatitis B in people with and without HIV has completed.
-
CLINICAL_TRIALS research · 2008-03-04Clinical Trial Update: Frequency of Parenteral and Non-Parenteral Exposures to Blood Among Healthcare Workers at the Clinical Center, NIH and at Seven Academic Hospitals in Japan
This clinical trial update reports the frequency of parenteral and non-parenteral blood exposures among healthcare workers at the NIH Clinic…
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Adefovir Dipivoxil to Treat Hepatitis B in HIV-Infected Patients [Phase 2]
Phase 2 clinical trial update evaluating adefovir dipivoxil for hepatitis B in HIV-infected patients. The study status is completed.
-
CLINICAL_TRIALS trial_result · 2007-11-15Clinical Trial Update: Hepsera Versus Hepsera Plus Lamivudine for Treatment of Chronic Hepatitis B in Patients With Normal ALT [Phase 4]
A Phase 4 trial comparing Hepsera (adefovir dipivoxil) alone versus Hepsera plus lamivudine in patients with chronic hepatitis B and normal …
-
CLINICAL_TRIALS trial_result · 2007-11-01Clinical Trial Update: Hepatitis Vaccination in HIV Infection: Role of Adjuvant Interleukin-2 [Phase 3]
A Phase 3 clinical trial is evaluating Hepatitis A vaccination in HIV-infected individuals with an adjuvant Interleukin-2. The current statu…
-
CLINICAL_TRIALS trial_result · 2007-09-21Clinical Trial Update: VaxTeen Hepatitis B Vaccine Booster Study [Phase 4]
This Phase 4 trial update reports the completion of a booster-dose study for the VaxTeen Hepatitis B Vaccine to prevent hepatitis B infectio…
-
CLINICAL_TRIALS trial_result · 2007-08-13Clinical Trial Update: Peginterferon Alfa-2a Plus Ribavirin for Chronic Hepatitis C/Hepatitis B Co-Infection and Chronic Hepatitis C [Phase 3]
Phase 3 clinical trial evaluating peginterferon alfa-2a plus ribavirin for chronic hepatitis B and hepatitis C co-infection and chronic hepa…
-
CLINICAL_TRIALS trial_result · 2007-08-01Clinical Trial Update: Long Term Follow-up of Pegylated-Interferon Alpha-2b
This document provides long-term follow-up data from a completed clinical trial of pegylated interferon alfa-2b in chronic hepatitis B.
-
CLINICAL_TRIALS trial_result · 2007-07-30Clinical Trial Update: Safety and Efficacy of SmithKline Beecham (GlaxoSmithKline [GSK]) Biologicals' Candidate Adjuvanted Vaccines (287615) [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating the safety and efficacy of GlaxoSmithKline's adjuvanted hepatitis B vaccine candidate (287615) has compl…